To include your compound in the COVID-19 Resource Center, submit it here.

SciClone begins Phase III Zadaxin trials

SCLN began two U.S. Phase III trials

Read the full 76 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE